Neoadjuvant Chemoradiation is Associated with Improved Survival in Resectable Gastric Cancer
Bose D, et al.
The Effect Of Previous Hormone Replacement Therapy on Post-Menopausal Symptoms in Hormone Receptor-Positive Breast Cancer Patients Treated with Anti-Estrogen Therapy
Chagpar AB; McMasters KM; Lewis J; and Edwards MJ
Does Adjuvant Chemoradiation Treatment Improve Survival in Patients Treated With Gastrectomy and D2-Lymphadenectomy for Gastric Cancer?
Coimbra FJ; Montagnini AL; Diniz AL; Ribeiro HS; Costa Jr, WL; Herman P; and Perini MV
Conservative Management of Breast Cancer in BRCA1/2 Mutation Carriers
Garcia-Etienne CA; Barile M; Gentilini OD; Botteri E; Rotmensz N; Farante G; Luini A; and Bonanni B
Pancreaticojejunostomy (PJ) with a Very Low Rate of Anastomotic Failure Related Complications: A Novel Technique
Grobmyer S; Kooby DA; Cance WG; Blumgart LH; and Hochwald SN
Mortality in the Elderly After Surgical Breast Cancer Therapy: Does Age Worsen Survival?
Kaur P, et al.
Positive Bone Marrow Biopsy is Associated with a Decreased Event Free Survival in Patients with Breast Cancer
Mascaro A; Vitelli CE; Baldi A; Farina M; Amini M; Piro F; and Fortunato L
Mastectomy Offers Improved Overall Survival Over Breast Conservation in Patients Presenting with Metastatic Breast Cancer
McGuire KP; Rodriguez A; Eisen S; Meade T; Cox CE; and Khakpour N
Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion
Reintgen DS; Pendas S; Jakub J; Chan H; Nobo C; Puleo C; and Shivers S
The Value of FDG-PET for Hepatic Surgery of Colorectal Liver Metastases: A Multicentre Randomized Clinical Study
Ruers T, et al.
The Prognostic Significance of Tumor Surgery in Patients with Primary Metastatic Breast Cancer
Ruiterkamp J; Voogd AC; Smilde T; Bosscha K; and Ernst MF
Survival Benefits After Sentinel Lymph Node Mapping in Colon Cancer as Compared to Conventional Surgery
Saha S, et al.
Does Chemotherapy or Radiotherapy Improve Outcomes for Surgically Resected Adenocarcinoma of the Stomach or Esophagus?
Solomon NL; Cheung MC; Byrne MM; and Koniaris LG
Optimizing Multimodality Therapy for Pancreatic Adenocarcinoma
Stitzenberg KB; Watson JC; and Hoffman JP
Outcome Following Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
Stokes JB, et al.
Analysis of Impact of Short Course Pre-Operative Radiotherapy on Local Relapse and Survival Outcomes in Patients Following Abdominoperineal Excision for Rectal Adenocarcinoma
Tayyab M; Cowley J; Garimella V; Gunn J; MacDonald AW; Hartley JE; and Monson JR
Optimizing Regional Melanoma Therapy: Systemic Sorafenib, an Inhibitor of the B-raf Kinase, Augments the Effectiveness of Concurrently Administered Regional Melphalan Chemotherapy in an Animal Model of Advanced Extremity Melanoma
Toshimitsu H; Augustin C; Padussis JC; and Tyler DS
Long Term Survival Results of Surgery Alone verses Surgery plus 5-Fluorouracil and Leucovorin for Stage II and Stage III Colon Cancer
Wilkinson NW; Yothers G; Lopa SH; Costantino J; Petrelli N; and Wolmark N
Validation Study of the S-Classification for Melanoma in Positive Sentinel Nodes
Younan RJ, et al.